Zobrazeno 1 - 10
of 57
pro vyhledávání: '"V V, Baker"'
Autor:
K. Shigemasa, C. Hu, C. M. West, J. Clarke, G. P. Pharham, T. H. Parmley, S. Korourian, V. V. Baker, T. J. O'Brien
Publikováno v:
Journal of the Society for Gynecologic Investigation. 4:95-102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a61be18358a2f01d52ea599875e0dbe
https://doi.org/10.1177/107155769700400209
https://doi.org/10.1177/107155769700400209
Publikováno v:
International journal of oncology. 7(4)
The development of human cancer is generally considered to be the result of genetic mutations that cause a progressively more malignant phenotype. We propose that such genetic changes can be observed in a small number of lymphocytic metaphase plates.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39adc20caa1cbd4b34d7187662d922c
https://pubmed.ncbi.nlm.nih.gov/21552901
https://pubmed.ncbi.nlm.nih.gov/21552901
Autor:
R. S. Freedman, Dilip K. Pandey, M. F. Mitchell, E. Johnson, Guillermo Tortolero-Luna, L. Whittaker, V. V. Baker, Anais Malpica
Publikováno v:
Gynecologic Cancer ISBN: 0387287949
GTD occurs in fewer than 1 in 1200 pregnancies in the United States, but it is much more common in Asia and Latin America, where its incidence may be as high as 1 in 200 pregnancies. Risk factors for GTD include advanced or young maternal age, low so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3b3805ec7e50faae45d83b4abdada99
https://doi.org/10.1007/0-387-28796-5_14
https://doi.org/10.1007/0-387-28796-5_14
Autor:
H, Wang, V V, Baker
Publikováno v:
Zhonghua fu chan ke za zhi. 35(2)
To observe the presence of synergistic efficacy between adenovirus-mediated bcl-Xs (Adv-bcl-Xs) gene therapy and cisplatin (CDDP) in ovarian cancer cell.NuTu-19 cells were infected by different titers of Adv-bcl-Xs and treated with CDDP in the meanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5792f25e83c205c831c9699c6ee38955
https://pubmed.ncbi.nlm.nih.gov/11809108
https://pubmed.ncbi.nlm.nih.gov/11809108
Autor:
C F, Levenback, G, Tortolero-Luna, D K, Pandey, A, Malpica, V V, Baker, L, Whittaker, E, Johnson, M, Follen Mitchell
Publikováno v:
Obstetrics and gynecology clinics of North America. 23(2)
Sarcomas are rare tumors with unpredictable prognosis. They are treated similarly to endometrial cancers. Little is known of epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0f75845f6810b5530990b9a5bcd11810
https://pubmed.ncbi.nlm.nih.gov/8784887
https://pubmed.ncbi.nlm.nih.gov/8784887
Autor:
C L, Edwards, G, Tortolero-Luna, A C, Linares, A, Malpica, V V, Baker, E, Cook, E, Johnson, M, Follen Mitchell
Publikováno v:
Obstetrics and gynecology clinics of North America. 23(2)
Vulvar carcinoma is a rare cancer. It is more frequent among older women, but the incidence is increasing among younger women. The incidence of VIN may be rising in younger women as well. Different factors have been associated with an increased risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a6fd4e3c90f35d10a2fe3c8bc6700d4e
https://pubmed.ncbi.nlm.nih.gov/8784883
https://pubmed.ncbi.nlm.nih.gov/8784883
Autor:
J T, Wharton, G, Tortolero-Luna, A C, Linares, A, Malpica, V V, Baker, E, Cook, E, Johnson, M, Follen Mitchell
Publikováno v:
Obstetrics and gynecology clinics of North America. 23(2)
Vaginal cancer is infrequent, but the morbidity associated with treatment is high. Delays in diagnosis account for presentations in advanced stages. Screening is probably not warranted given the low incidence, but inspection of the vagina should be p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::862e1541d20edb4caf3d59bcf3689050
https://pubmed.ncbi.nlm.nih.gov/8784884
https://pubmed.ncbi.nlm.nih.gov/8784884
Autor:
D M, Gershenson, G, Tortolero-Luna, A, Malpica, V V, Baker, L, Whittaker, E, Johnson, M, Follen Mitchell
Publikováno v:
Obstetrics and gynecology clinics of North America. 23(2)
Ovarian cancer accounts for only 4% of cancers in women, but it is the leading cause of death from gynecologic malignancies in the United States. In the general population, a woman's lifetime risk of ovarian cancer is 1.4% but this risk can increase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0d8d9f517b40df5f42b28940ec958bda
https://pubmed.ncbi.nlm.nih.gov/8784888
https://pubmed.ncbi.nlm.nih.gov/8784888
Autor:
T W, Burke, G, Tortolero-Luna, A, Malpica, V V, Baker, L, Whittaker, E, Johnson, M, Follen Mitchell
Publikováno v:
Obstetrics and gynecology clinics of North America. 23(2)
Endometrial cancer is the most frequently seen gynecologic neoplasm, but it fortunately has low mortality, which is due largely to its presentation with abnormal bleeding and its subsequent early diagnosis. The morbidity associated with therapy for e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f87143b2c11d01bfe94b9b69fea75357
https://pubmed.ncbi.nlm.nih.gov/8784886
https://pubmed.ncbi.nlm.nih.gov/8784886
Autor:
R S, Freedman, G, Tortolero-Luna, D K, Pandey, A, Malpica, V V, Baker, L, Whittaker, E, Johnson, M, Follen Mitchell
Publikováno v:
Obstetrics and gynecology clinics of North America. 23(2)
GTD occurs in fewer than 1 in 1200 pregnancies in the United States, but it is much more common in Asia and Latin America, where its incidence may be as high as 1 in 200 pregnancies. Risk factors for GTD include advanced or young maternal age, low so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9654c60ed26dc635cd6f632aef0ca825
https://pubmed.ncbi.nlm.nih.gov/8784889
https://pubmed.ncbi.nlm.nih.gov/8784889